Supplemental Figure 1 from Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population

Key Points

• Discovery-based lipidomics analysis improves early detection of ovarian cancer in symptomatic patients, enhancing diagnostic accuracy.
• The incorporation of protein biomarkers with lipidomics could facilitate earlier identification of ovarian cancer, potentially leading to better outcomes.
• Machine learning algorithms are utilized to analyze data, which may boost predictive capabilities in identifying at-risk patients.
• These findings highlight the promising role of combining lipidomic and protein data for effective cancer screening strategies.